Roxion 40 EC

Primær information

  • Handelsnavn:
  • Roxion 40 EC Emulsionskoncentrat
  • Lægemiddelform:
  • Emulsionskoncentrat
  • Sammensætning:
  • 400 g/l dimethoat
  • Brugt til:
  • Planter
  • Medicin typen:
  • agrokemiske

Dokumenter

  • for den brede offentlighed:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for offentligheden.

  • for sundhedspersonale:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for sundhedspersonale.

Lokation

  • Fås i:
  • Roxion 40 EC Emulsionskoncentrat
    Danmark
  • Sprog:
  • dansk

Andre oplysninger

Status

  • Kilde:
  • SEGES Landbrug & Fødevarer
  • Autorisation status:
  • Udgået
  • Autorisationsnummer:
  • 5-93
  • Sidste ændring:
  • 26-02-2018
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.

    Anmode informationsbrochure for offentligheden.

20-4-2018

Pending EC decision:  Credelio, lotilaner, Opinion date: 19-Apr-2018

Pending EC decision: Credelio, lotilaner, Opinion date: 19-Apr-2018

Europe - EMA - European Medicines Agency

20-4-2018

Pending EC decision:  Alsitek, masitinib, Opinion date: 18-Apr-2018

Pending EC decision: Alsitek, masitinib, Opinion date: 18-Apr-2018

Europe - EMA - European Medicines Agency

9-4-2018

Club 13 Recalls Kratom Maeng Da Red Powder and Capsules Because of Possible Health Risk

Club 13 Recalls Kratom Maeng Da Red Powder and Capsules Because of Possible Health Risk

Club 13 of St. Augustine, FL is recalling 15-gram, 30-gram, 90-gram, 150-gram, and 454-gram pouches, and all bulk orders of "Maeng Da Red" kratom powder; and 5-count, 25-count, 50-count, 100-count, 120-count capsule, and all bulk capsule orders of “Maeng Da Red” kratom bottles; and 5-count, 20-count, 25-count, 40-count, 50-count capsule “Maeng Da Red XS” kratom bottles because they have the potential to be contaminated with Salmonella , an organism which can cause serious and sometimes fatal infections i...

FDA - U.S. Food and Drug Administration

23-3-2018

Pending EC decision:  Cabometyx , cabozantinib, Opinion date: 22-Mar-2018

Pending EC decision: Cabometyx , cabozantinib, Opinion date: 22-Mar-2018

Europe - EMA - European Medicines Agency

23-3-2018

Pending EC decision:  Prasugrel Mylan, prasugrel, Opinion date: 22-Mar-2018

Pending EC decision: Prasugrel Mylan, prasugrel, Opinion date: 22-Mar-2018

Europe - EMA - European Medicines Agency

23-3-2018

Pending EC decision:  Repatha, evolocumab, Opinion date: 22-Mar-2018

Pending EC decision: Repatha, evolocumab, Opinion date: 22-Mar-2018

Europe - EMA - European Medicines Agency

23-3-2018

Pending EC decision:  Dexxience, betrixaban, Opinion date: 22-Mar-2018

Pending EC decision: Dexxience, betrixaban, Opinion date: 22-Mar-2018

Europe - EMA - European Medicines Agency

23-3-2018

Pending EC decision:  Rubraca, rucaparib, Opinion date: 22-Mar-2018

Pending EC decision: Rubraca, rucaparib, Opinion date: 22-Mar-2018

Europe - EMA - European Medicines Agency

23-3-2018

Pending EC decision:  Pemetrexed Krka, pemetrexed, Opinion date: 22-Mar-2018

Pending EC decision: Pemetrexed Krka, pemetrexed, Opinion date: 22-Mar-2018

Europe - EMA - European Medicines Agency

23-3-2018

Pending EC decision:  Timloze, abaloparatide, Opinion date: 22-Mar-2018

Pending EC decision: Timloze, abaloparatide, Opinion date: 22-Mar-2018

Europe - EMA - European Medicines Agency

23-3-2018

Pending EC decision:  Zessly, infliximab, Opinion date: 22-Mar-2018

Pending EC decision: Zessly, infliximab, Opinion date: 22-Mar-2018

Europe - EMA - European Medicines Agency

23-3-2018

Pending EC decision:  Kanjinti, trastuzumab, Opinion date: 22-Mar-2018

Pending EC decision: Kanjinti, trastuzumab, Opinion date: 22-Mar-2018

Europe - EMA - European Medicines Agency

23-3-2018

Pending EC decision:  Ivemend, fosaprepitant, Opinion date: 22-Mar-2018

Pending EC decision: Ivemend, fosaprepitant, Opinion date: 22-Mar-2018

Europe - EMA - European Medicines Agency

23-3-2018

Pending EC decision:  Eladynos, abaloparatide, Opinion date: 22-Mar-2018

Pending EC decision: Eladynos, abaloparatide, Opinion date: 22-Mar-2018

Europe - EMA - European Medicines Agency

16-3-2018

Pending EC decision:  Onsior, robenacoxib, Opinion date: 15-Mar-2018

Pending EC decision: Onsior, robenacoxib, Opinion date: 15-Mar-2018

Europe - EMA - European Medicines Agency

16-3-2018

Pending EC decision:  Semintra, telmisartan, Opinion date: 15-Mar-2018

Pending EC decision: Semintra, telmisartan, Opinion date: 15-Mar-2018

Europe - EMA - European Medicines Agency

16-3-2018

Tobacco and related products

Tobacco and related products

The Tobacco Products Directive (2014/40/EU) lays down rules relating to the manufacture, presentation and sale of tobacco and related products (other smoking products, vaping products). While it does not establish a marketing authorisation system, the Directive requires manufacturers and importers to declare these products to the competent authorities of the Member States before they can be marketed. Their composition, emissions, toxicological data on the ingredients, in-depth studies for certain additiv...

France - Agence Nationale du Médicament Vétérinaire

6-3-2018

Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Methylprednisolone Sodium Succinate for Injection, USP, 40mg, 125mg, and 1g Due to High Out of Specification Impurity Results

Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Methylprednisolone Sodium Succinate for Injection, USP, 40mg, 125mg, and 1g Due to High Out of Specification Impurity Results

Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of ten lots of Methylprednisolone Sodium Succinate for Injection, USP, 40mg, 125mg, and 1g. A detailed listing of products and lots is listed below. These products were manufactured by Gland Pharma Ltd. and distributed by Sagent Pharmaceuticals.

FDA - U.S. Food and Drug Administration

6-3-2018

Methylprednisolone Sodium Succinate for Injection 40mg, 125mg, and 1g by Sagent Pharmaceuticals: Recall - High Out of Specification Impurity Results

Methylprednisolone Sodium Succinate for Injection 40mg, 125mg, and 1g by Sagent Pharmaceuticals: Recall - High Out of Specification Impurity Results

An elevated impurity has the potential to decrease effectiveness of the product in patients. Posted: 03/06/2018

FDA - U.S. Food and Drug Administration

23-2-2018

Pending EC decision:  Alpivab, peramivir, Opinion date: 22-Feb-2018

Pending EC decision: Alpivab, peramivir, Opinion date: 22-Feb-2018

Europe - EMA - European Medicines Agency

23-2-2018

Pending EC decision:  Kineret, anakinra, Opinion date: 22-Feb-2018

Pending EC decision: Kineret, anakinra, Opinion date: 22-Feb-2018

Europe - EMA - European Medicines Agency

23-2-2018

Pending EC decision:  Isentress, raltegravir, Opinion date: 22-Feb-2018

Pending EC decision: Isentress, raltegravir, Opinion date: 22-Feb-2018

Europe - EMA - European Medicines Agency

23-2-2018

Pending EC decision:  Xgeva, denosumab, Opinion date: 22-Feb-2018

Pending EC decision: Xgeva, denosumab, Opinion date: 22-Feb-2018

Europe - EMA - European Medicines Agency

23-2-2018

Pending EC decision:  Mylotarg, gemtuzumab ozogamicin, Opinion date: 22-Feb-2018

Pending EC decision: Mylotarg, gemtuzumab ozogamicin, Opinion date: 22-Feb-2018

Europe - EMA - European Medicines Agency

23-2-2018

Pending EC decision:  Sutent, sunitinib, Opinion date: 22-Feb-2018

Pending EC decision: Sutent, sunitinib, Opinion date: 22-Feb-2018

Europe - EMA - European Medicines Agency

23-2-2018

Pending EC decision:  Nerlynx, neratinib, Opinion date: 22-Feb-2018

Pending EC decision: Nerlynx, neratinib, Opinion date: 22-Feb-2018

Europe - EMA - European Medicines Agency

23-2-2018

Pending EC decision:  Feraccru, ferric maltol, Opinion date: 22-Feb-2018

Pending EC decision: Feraccru, ferric maltol, Opinion date: 22-Feb-2018

Europe - EMA - European Medicines Agency

23-2-2018

Pending EC decision:  Amglidia, glibenclamide, Opinion date: 22-Feb-2018

Pending EC decision: Amglidia, glibenclamide, Opinion date: 22-Feb-2018

Europe - EMA - European Medicines Agency

23-2-2018

Pending EC decision:  Bosulif, bosutinib, Opinion date: 22-Feb-2018

Pending EC decision: Bosulif, bosutinib, Opinion date: 22-Feb-2018

Europe - EMA - European Medicines Agency

23-2-2018

Pending EC decision:  Lynparza, olaparib, Opinion date: 22-Feb-2018

Pending EC decision: Lynparza, olaparib, Opinion date: 22-Feb-2018

Europe - EMA - European Medicines Agency

16-2-2018

Pending EC decision:  Metacam, meloxicam, Opinion date: 15-Feb-2018

Pending EC decision: Metacam, meloxicam, Opinion date: 15-Feb-2018

Europe - EMA - European Medicines Agency

16-2-2018

Pending EC decision:  Clevor, ropinirole, Opinion date: 15-Feb-2018

Pending EC decision: Clevor, ropinirole, Opinion date: 15-Feb-2018

Europe - EMA - European Medicines Agency

19-4-2018

More Than 40% of Americans Breathe Dirty Air: Report

More Than 40% of Americans Breathe Dirty Air: Report

Title: More Than 40% of Americans Breathe Dirty Air: ReportCategory: Health NewsCreated: 4/18/2018 12:00:00 AMLast Editorial Review: 4/18/2018 12:00:00 AM

US - MedicineNet

16-3-2018

Scientific guideline:  Public consultation concerning a request for CVMP opinion under Article 30(3) of Regulation (EC) No 726/2004 on the risk for the consumer resulting from the use of diethanolamine as an excipient in veterinary medicinal products for

Scientific guideline: Public consultation concerning a request for CVMP opinion under Article 30(3) of Regulation (EC) No 726/2004 on the risk for the consumer resulting from the use of diethanolamine as an excipient in veterinary medicinal products for

The European Medicines Agency is seeking stakeholder input on any information or data that may help its Committee for Medicinal Products for Veterinary Use (CVMP) to reach an opinion on consumer risk from using diethanolamine as an excipient in veterinary medicines for food-producing animals.

Europe - EMA - European Medicines Agency

16-3-2018

MRL pending EC decision:  Diflubenzuron - Summary opinion of the CVMP on the establishment of maximum residue limits AA

MRL pending EC decision: Diflubenzuron - Summary opinion of the CVMP on the establishment of maximum residue limits AA

On 15 March 2018, the Committee for Medicinal Products for Veterinary Use (CVMP) adopted an opinion recommending the amendment of the entry for diflubenzuron.

Europe - EMA - European Medicines Agency

16-3-2018

MRL pending EC decision:  Isoflurane - Summary opinion of the CVMP on the establishment of maximum residue limits

MRL pending EC decision: Isoflurane - Summary opinion of the CVMP on the establishment of maximum residue limits

On 15 March 2018, the Committee for Medicinal Products for Veterinary Use (CVMP) adopted an opinion2 recommending the establishment of MRLs for isoflurane in porcine species and amending the existing entry for Equidae.

Europe - EMA - European Medicines Agency

28-2-2018

Voltaren Gel vs. Naprosyn

Voltaren Gel vs. Naprosyn

Voltaren Gel (diclofenac sodium topical gel) and Naprosyn (naproxen; other brand names: EC-Naprosyn and Anaprox/Anaprox DS) are nonsteroidal anti-inflammatory drugs (NSAIDs) used to treat osteoarthritis joint pain.

US - RxList

23-2-2018

TYLAN 40 SULFA-G (Tylosin Phosphate And Sulfamethazine) Granule [Elanco]

TYLAN 40 SULFA-G (Tylosin Phosphate And Sulfamethazine) Granule [Elanco]

Updated Date: Feb 23, 2018 EST

US - DailyMed

22-2-2018

TYLAN 40 (Tylosin Phosphate) Granule [Elanco US Inc.]

TYLAN 40 (Tylosin Phosphate) Granule [Elanco US Inc.]

Updated Date: Feb 22, 2018 EST

US - DailyMed